Durham’s Innocrin Pharmaceuticals raises $28 million in funding

April 15, 2015 05:40 PM

More Videos

  • Duke engineers create artificial heart muscle for heart attack victims

    Biomedical engineers at Duke have created a fully functioning artificial human heart muscle large enough to patch over damage typically seen in patients who have suffered a heart attack. The advance takes a major step toward the end goal of repairing dead heart muscle in human patients.